摘要: A proposal by a Melbourne based biotechnology company, Autogen, to establish database of genetic information on the population Tonga in South Pacific is floundering after opposition from church and pro-democracy groups. In November 2000 Autogen triumphantly announced Australian Stock Exchange that it had signed an agreement with Tongan health ministry undertake project “aimed at identifying genes cause common diseases using unique resources Kingdom Tonga.” The product alliance between Merck Lipha, subsidiary German pharmaceutical giant Merck. holds 15% stake …